Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Rivaroxaban Film-coated Tablets under Fed Conditions
TCTR20250319017Phase 1Completed
- Sponsor
- Mankind Pharma
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of rivaroxaban (2 arms), sponsored by Mankind Pharma. Started Jun 2025; status: completed.
02
Drugs
rivaroxaban
Beyond the preview
Go deeper on TCTR20250319017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250319017.